Related Experiment Video
Updated: Sep 1, 2025

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Systematic Infection of Chlamydia Pneumoniae
Chlamydia pneumoniae (Cpn) infection can spread systematically, contributing to chronic diseases like atherosclerosis and Alzheimer's. This review explores Cpn's mechanisms, immune responses, and links to extrapulmonary conditions.
Area of Science:
- Microbiology
- Immunology
- Pathology
Background:
- Chlamydia pneumoniae (Cpn) is a common respiratory pathogen and obligate intracellular parasite.
- Cpn infection can disseminate systemically via blood transmission, involving monocytes, lymphocytes, and macrophages.
- This dissemination can lead to extrapulmonary symptoms and chronic conditions.
Purpose of the Study:
- To review the mechanisms of Cpn infection in host cells.
- To summarize the host immune response to Cpn infection.
- To explore the association between Cpn infection and chronic diseases.
Main Methods:
- Literature review of Cpn infection mechanisms.
- Analysis of immune responses to Cpn.
- Examination of Cpn's role in chronic disease development.
Main Results:
- Cpn DNA has been detected in atherosclerotic (AS) plaque, nerve tissues, and joint synovium.
- Evidence supports Cpn's involvement in extrapulmonary chronic diseases.
- Cpn infection is linked to systemic manifestations.
Conclusions:
- Cpn infection is implicated in the pathogenesis of chronic diseases, including atherosclerosis, Alzheimer's Disease (AD), and reactive arthritis.
- Both in vivo and in vitro studies support the link between Cpn and chronic disease development.
- Understanding Cpn's role is crucial for managing these conditions.
More Related Videos
08:25Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling
Published on: April 7, 2015
12:21A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
Published on: September 28, 2022
Related Concept Videos
Bacterial Phylum Chlamydiae
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology
Pneumonia III: Complications and Assessment
Sexually Transmitted Infections
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: